{"schema_version":"secwatch.filing_event.v1","accession":"0001759655-23-000209","form_type":"8-K","ticker":"PRVA","cik":"0001759655","company_name":"Privia Health Group, Inc.","filed_at":"2023-11-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.339639+00:00","generated_at":"2026-06-08T22:38:43.579146+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Privia Health Q3 revenue $417M (+22%); net income $5.6M; raises FY guidance","bullets":["Q3 rev $417.3M (+22% YoY); GAAP net income $5.6M vs $1.6M.","Adjusted net income $21.1M ($0.17) vs $16.7M ($0.13) (+26%).","Implemented providers 4,105 (+14%); attributed lives 1.09M (+29%).","FY guidance raised: Platform Contribution above high end; Adj. EBITDA $70-74M.","Entering South Carolina with Greenville ENT (20 providers); H1 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001759655-23-000209","json":"https://secwatch.observer/filing/0001759655-23-000209.json","markdown":"https://secwatch.observer/filing/0001759655-23-000209.md","text":"https://secwatch.observer/filing/0001759655-23-000209.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1759655/000175965523000209/0001759655-23-000209-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1759655/000175965523000209/prva-20231103.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T22:38:43.579146+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"839e43ac30ddc193d794407ff3889ee6506b52ea","claim":"Privia Health Group, Inc. reported the third quarter ended September 30, 2023 results: revenue $417.3 million, net income $5.6 million, EPS $0.05 per share.","evidence_excerpt":"Total revenue for the third quarter of 2023 was $417.3 million, compared to total revenue of $342.9 million for the prior year third quarter (+21.7%). Gross Profit for the third quarter of 2023 was $90.6 million, compared to $76.9 million for the prior year third quarter. Operating income for the third quarter of 2023 was $5.5 million, compared to operating loss of $(4.6) million for the prior year third quarter. Net income for the third quarter of 2023 was $5.6 million, or $0.05 per share, compared to net income of $1.6 million, or $0.01 per share, for the third quarter of 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1759655/000175965523000209/0001759655-23-000209-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the third quarter ended September 30, 2023"},{"label":"Revenue","value":"$417.3 million"},{"label":"Net income","value":"$5.6 million"},{"label":"EPS","value":"$0.05 per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"97c2eefa144970cc662496f06b502164e93069c4","claim":"Privia Health Group, Inc. reported the nine months ended September 30, 2023 results: revenue $1.22 billion, net income $20.2 million, EPS $0.16 per diluted share.","evidence_excerpt":"Total revenue was $1.22 billion for the nine months ended September 30, 2023, an increase from $992.2 million for the same period in 2022 (+22.6%). Operating income for the first nine months of 2023 was $19.2 million, compared to operating loss of $(21.4) million for the same period in 2022. Net income for the first nine months of 2023 was $20.2 million, or $0.16 per diluted share, compared to net loss of $(26.4) million, or $(0.24) per diluted share, for the same period in 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1759655/000175965523000209/0001759655-23-000209-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the nine months ended September 30, 2023"},{"label":"Revenue","value":"$1.22 billion"},{"label":"Net income","value":"$20.2 million"},{"label":"EPS","value":"$0.16 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}